Skip to main content

HSPA12A Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-85079

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-85079-0.1ml

Key Product Details

Species Reactivity

Human

Applications

Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit

Concentration

0.5 mg/ml

Product Specifications

Immunogen

The immunogen is a synthetic peptide directed towards the N-terminal region of Human HSPA12A. Peptide sequence: KALEIFAYALQYFKEQALKELSDQAGSEFENSDVRWVITVPAIWKQPAKQ The peptide sequence for this immunogen was taken from within the described region.

Clonality

Polyclonal

Host

Rabbit

Scientific Data Images for HSPA12A Antibody

Western Blot: HSPA12A Antibody [NBP2-85079]

Western Blot: HSPA12A Antibody [NBP2-85079]

Western Blot: HSPA12A Antibody [NBP2-85079] - Host: Rabbit. Target Name: HSPA12A. Sample Type: HT1080 Whole Cell lysates. Antibody Dilution: 1.0ug/ml

Applications for HSPA12A Antibody

Application
Recommended Usage

Western Blot

1.0 ug/ml

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

PBS, 2% Sucrose

Preservative

0.09% Sodium Azide

Concentration

0.5 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: HSPA12A

Alternate Names

FLJ13874, heat shock 70 kDa protein 12A, heat shock 70kD protein 12A, heat shock 70kDa protein 12A, KIAA0417

Gene Symbol

HSPA12A

Additional HSPA12A Products

Product Documents for HSPA12A Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for HSPA12A Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...